Heron Therapeutics | HRTX - ايرادات المبيعات





مبيعات تغيير تاريخ
ALKERMES USD 496.01M 103.1M 2026-06
Alnylam Pharmaceuticals USD 1.29B 120M 2026-06
Amarin USD 49.22M 451K 2025-12
ANI Pharmaceuticals USD 266M 28.5M 2026-06
Anika Therapeutics USD 30.62M 2.8M 2025-12
Arrowhead Research USD 75.23M 1.49M 2026-06
Eisai JPY 234.33B 28.9B 2026-06
Emergent BioSolutions USD 276.6M 6.1M 2023-12
GlaxoSmithKline GBP 8.41B 781M 2026-06
Heron Therapeutics USD 40.59M 2.38M 2025-12
Insmed USD 425.49M 119.53M 2026-06
Ligand Pharmaceuticals USD 83.7M 31.98M 2026-06
Merck USD 16.6B 310M 2026-06
Nektar Therapeutics USD 10.86M 10.95M 2026-03
Neurocrine Biosciences USD 959M 148M 2026-06
Pacira USD 192.4M 15.4M 2026-06
Regeneron Pharmaceuticals USD 4.29B 690M 2026-06
Roche Holding CHF 30.36B 14.71B 2026-06
Sangamo BioSciences USD 356K 125K 2024-06
Ultragenyx Pharmaceutical USD 214M 78M 2026-06
Veracyte USD 150.32M 11.25M 2026-06
Vertex Pharmaceuticals USD 3.33B 340M 2026-06